Shandong Jincheng Pharmaceutical Group Co., Ltd
300233.SZ · SHZ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | CN¥208 | CN¥193 | CN¥286 | CN¥123 |
| Dep. & Amort. | CN¥319 | CN¥312 | CN¥259 | CN¥233 |
| Deferred Tax | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| Stock-Based Comp. | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| Change in WC | -CN¥281 | CN¥121 | -CN¥496 | -CN¥4 |
| Other Non-Cash | CN¥50 | CN¥38 | CN¥91 | CN¥99 |
| Operating Cash Flow | CN¥297 | CN¥664 | CN¥256 | CN¥437 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -CN¥143 | -CN¥343 | -CN¥374 | -CN¥376 |
| Net Acquisitions | CN¥0 | CN¥0 | CN¥6 | CN¥6 |
| Inv. Purchases | -CN¥4 | -CN¥5 | -CN¥15 | -CN¥8 |
| Inv. Sales/Matur. | CN¥0 | CN¥2 | CN¥5 | CN¥150 |
| Other Inv. Act. | CN¥62 | CN¥36 | CN¥20 | -CN¥4 |
| Investing Cash Flow | -CN¥84 | -CN¥310 | -CN¥358 | -CN¥232 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -CN¥42 | -CN¥101 | CN¥61 | -CN¥1 |
| Stock Issued | CN¥0 | CN¥0 | CN¥57 | CN¥0 |
| Stock Repurch. | -CN¥55 | CN¥0 | -CN¥57 | -CN¥80 |
| Dividends Paid | -CN¥132 | -CN¥84 | -CN¥105 | -CN¥105 |
| Other Fin. Act. | -CN¥15 | -CN¥59 | CN¥47 | -CN¥33 |
| Financing Cash Flow | -CN¥244 | -CN¥243 | CN¥4 | -CN¥192 |
| Forex Effect | CN¥6 | CN¥3 | CN¥4 | -CN¥5 |
| Net Chg. in Cash | -CN¥26 | CN¥114 | -CN¥94 | CN¥9 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | CN¥904 | CN¥790 | CN¥884 | CN¥875 |
| End Cash | CN¥878 | CN¥904 | CN¥790 | CN¥884 |
| Free Cash Flow | CN¥154 | CN¥321 | -CN¥118 | CN¥61 |